APA ציטוט

Carreno, G., Boult, J. K. R., Apps, J., Gonzalez-Meljem, J. M., Haston, S., Guiho, R., . . . Martinez-Barbera, J. P. (2019). SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. Endocr Relat Cancer.

Citação norma Chicago

Carreno, G., et al. "SHH Pathway Inhibition Is Protumourigenic in Adamantinomatous Craniopharyngioma." Endocr Relat Cancer 2019.

ציטוט MLA

Carreno, G., et al. "SHH Pathway Inhibition Is Protumourigenic in Adamantinomatous Craniopharyngioma." Endocr Relat Cancer 2019.